News Agency
Men's Weekly

Abivax: ABX464 inhibits replication of SARS-CoV-2 (COVID-19) in reconstituted human respiratory epithelium model

  • Written by Media Outreach

ABX464 is the only drug candidate with a potential triple action for COVID-19 treatment: antiviral, anti-inflammatory and tissue repair

 

  • ABX464, as assessed by RTqPCR, inhibits in vitro viral replication of SARS-CoV-2 (COVID-19)
  • Simultaneously, Abivax receives ANSM and CPP clearance[1] to test ABX464 as promising COVID-19 therapeutic candidate...

Read more: Abivax: ABX464 inhibits replication of SARS-CoV-2 (COVID-19) in reconstituted human respiratory...

Code Meets Creativity: The Intersection of Software Development and Web Design

Introduction: Where Code Meets Creativity Building a strong web-based presence is no longer just about stunning visuals in the digital world of today. New websites and software require an ideal mixture of innovation and precision. This overlapping of web design and... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion